首页|复方托吡卡胺滴眼结合护理干预治疗高血压性视网膜病变患者的临床效果

复方托吡卡胺滴眼结合护理干预治疗高血压性视网膜病变患者的临床效果

扫码查看
目的 分析高血压性视网膜病变患者采用复方托吡卡胺滴眼结合护理干预治疗的临床效果.方法 选取2016年7月~2017年6月在温州医科大学附属眼视光医院进行治疗的80例高血压性视网膜病变患者进行研究,将其随机分为观察组和对照组,每组40例.观察组采用复方托吡卡胺滴眼结合护理干预治疗,对照组仅采用复方托吡卡胺滴眼治疗.比较2组患者的视网膜病变变化情况、血压变化情况.结果 治疗后,2组患者的病变情况均有改善,观察组的改善情况优于对照组,差异均有统计学意义(P<0.05).2组患者治疗前的血压差异均无统计学意义;治疗后,2组收缩压和舒张压较治疗前均有所下降,且2组相比差异均有统计学意义(P<0.05).与治疗前比较,观察组治疗后各项指标的改善程度均优于对照组,差异有统计学意义(P<0.05).结论 高血压性视网膜病变患者采用复方托吡卡胺滴眼结合护理干预治疗,能够改善视网膜病变情况.
Clinical analysis of hypertensive retinopathy with compound tropicamide eye drops combined with nursing intervention therapy
Objective To analyze the clinical effect of compound tropicamide eye drops with nursing intervention therapy for hypertensive retinopathy. Methods 80 cases of hypertensive retinopathy treated in our hospital from July 2016 to June 2017 were studied, and randomly divide them into the observation group and the control group, 40 cases in each group. The observation group was treated with compound tropicamide eye drops combined with nursing intervention, the control group only with compound tropicamide eye treatment. The primary efficacy outcome measure was the change of degree of retinopathy, blood pressure. Results The blood pressure including systolic blood pressure [the observation group:(119.6±11.2) mmHg, the control group: (132±14.5) mmHg]and diastolic blood pressure [in the observation group: (73.1±9.6) mmHg, the control group: (84.2±10.2) mmHg] before and after treatment showed a statistically significant difference between two groups (P<0.05). After treatment, all the indexes were significantly decreased, the difference was statistically significant (P<0.05). Compared with the treatment before treatment, the improvement of the indexes in the observation group was better than that in the control group, and the difference was statistically significant (P<0.05). Conclusion Use of compoud tropicamide eye drops combined with nursing intervention, for hypertensive retinopathy can help to relief the degree of the angiosclerosis.

hypertensive retinopathytropicamidenursing intervention

吴培瑜、胡志翔

展开 >

温州医科大学附属眼视光医院 眼科,浙江 温州 325000

高血压性视网膜病变 复方托吡卡胺 护理干预

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(11)
  • 10